# Ventripoint Diagnostics, Ltd.

- Location (FDA's records): Toronto, CA
- FDA decisions: 3 (2018–2025): 3 510(k) clearances
- Product codes: LLZ (1), IYN (1), QIH (1)
- 510(k) review time since 2016: median 150 days, against 107 for FDA's reviews in the same codes and years (0 of 3 faster)
- Predicates its devices cite: 3 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Ge Vingmed Ultrasound AS: 1 (https://510kreport.com/company/ge-vingmed-ultrasound)
- Ventripoint, Inc.: 1 (https://510kreport.com/company/ventripoint)

## Its most-cited devices
- K191493: Ventripoint Medical System Plus (VMS+) 3.0 (2019), cited by 1

## Recent decisions
- K241222: Ventripoint Medical System Plus (VMS+) 4.0 (Feb 26, 2025)
- K191493: Ventripoint Medical System Plus (VMS+) 3.0 (Oct 16, 2019)
- K173810: Ventripoint Medical System Plus (VMS+) (May 14, 2018)

Source page: https://510kreport.com/company/ventripoint-diagnostics